Page last updated: 2024-12-06

(-)-catechin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(-)-Catechin is a flavan-3-ol, a type of flavonoid. It is found in many fruits, vegetables, and beverages, such as apples, grapes, green tea, and red wine. (-)-Catechin is a potent antioxidant, which means it can protect cells from damage caused by free radicals. Free radicals are unstable molecules that can damage cells and contribute to the development of diseases such as cancer, heart disease, and Alzheimer's disease. (-)-Catechin has also been shown to have anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. It is thought to work by inhibiting the activity of enzymes that are involved in inflammation and cancer cell growth. (-)-Catechin is also a good source of dietary fiber, which can help to lower cholesterol levels and improve digestion. (-)-Catechin is being studied for its potential to prevent and treat a variety of diseases. Researchers are investigating its effects on heart health, cancer, diabetes, and Alzheimer's disease. (-)-Catechin is generally considered to be safe for human consumption. However, it is important to note that some people may experience side effects, such as nausea, vomiting, or diarrhea, after consuming large amounts of (-)-catechin. It is also important to talk to your doctor before taking (-)-catechin supplements, especially if you have any underlying medical conditions or are taking any medications.'

(-)-catechin : The (-)-enantiomer of catechin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73160
CHEMBL ID200715
CHEBI ID33992
SCHEMBL ID166733

Synonyms (52)

Synonym
BCBCMAP01_000008
SMP1_000325
(-)-catechol
catechin, alpha
nsc-81746
(+/-) trans-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
18829-70-4
(2s,3r)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol
(-)-catechin
2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol, (2s-trans)
NSC81746 ,
(-)-catechin, >=97% (hplc), from green tea
catechin l-form
EE68D890-72E6-4BA1-9AD2-038C19D48620
chebi:33992 ,
CHEMBL200715 ,
bdbm50236527
(2s,3r)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-chromene-3,5,7-triol
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-1h-benzopyran-3,5,7-triol
nsc 81746
1h-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2s,3r)-
(2s-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
fhb0gx3d44 ,
einecs 242-611-7
unii-fhb0gx3d44
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
SCHEMBL166733
ent-catechin
l-catechin
(2s,3r)-ent-catechin
2h-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2s,3r)-
l-catechol
(-)-(2s,3r)-catechin
cianidanol, (-)-
catechin l-form [mi]
mfcd00135997
(-)-trans-3,3',4',5,7-pentahydroxyflavane
DTXSID40172174
AKOS027446338
AS-73252
(2s,3r)-catechin
J-012129
E76537
CS-W016715
HY-N0898A
Q27115730
(-)-cianidanol
trans-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol
()-catechin
M5O ,
(2~{s},3~{r})-2-[3,4-bis(oxidanyl)phenyl]-3,4-dihydro-2~{h}-chromene-3,5,7-triol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
catechinMembers of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Maltase-glucoamylase, intestinalHomo sapiens (human)IC50 (µMol)53.80000.04003.46529.0000AID1514076
Lysosomal alpha-glucosidaseHomo sapiens (human)IC50 (µMol)53.80000.06002.28897.8000AID1514076
Glucose-6-phosphate 1-dehydrogenaseSaccharomyces cerevisiae S288CIC50 (µMol)1,000.00000.18000.22500.2500AID319369
Sucrase-isomaltase, intestinalHomo sapiens (human)IC50 (µMol)53.80000.04902.72947.8000AID1514076
6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)IC50 (µMol)1,000.00000.21000.91501.4500AID319370
Beta-secretase 1Homo sapiens (human)IC50 (µMol)30.00000.00061.619410.0000AID44249
Probable maltase-glucoamylase 2Homo sapiens (human)IC50 (µMol)53.80000.54004.02447.8000AID1514076
Sialidase-2Homo sapiens (human)IC50 (µMol)1,000.00003.90006.73337.8000AID466938
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mu-type opioid receptorHomo sapiens (human)Ke2.40000.00000.24883.0700AID311281
Delta-type opioid receptorHomo sapiens (human)Ke1.77000.00010.69799.0700AID311282
Kappa-type opioid receptorHomo sapiens (human)Ke3.60000.00000.35405.8100AID311280
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (98)

Processvia Protein(s)Taxonomy
maltose catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
starch catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
dextrin catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
maltose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
regulation of the force of heart contractionLysosomal alpha-glucosidaseHomo sapiens (human)
diaphragm contractionLysosomal alpha-glucosidaseHomo sapiens (human)
heart morphogenesisLysosomal alpha-glucosidaseHomo sapiens (human)
glycogen catabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
sucrose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
glucose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
lysosome organizationLysosomal alpha-glucosidaseHomo sapiens (human)
locomotory behaviorLysosomal alpha-glucosidaseHomo sapiens (human)
tissue developmentLysosomal alpha-glucosidaseHomo sapiens (human)
aorta developmentLysosomal alpha-glucosidaseHomo sapiens (human)
vacuolar sequesteringLysosomal alpha-glucosidaseHomo sapiens (human)
muscle cell cellular homeostasisLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling postureLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling balanceLysosomal alpha-glucosidaseHomo sapiens (human)
cardiac muscle contractionLysosomal alpha-glucosidaseHomo sapiens (human)
glycophagyLysosomal alpha-glucosidaseHomo sapiens (human)
sucrose catabolic processSucrase-isomaltase, intestinalHomo sapiens (human)
polysaccharide digestionSucrase-isomaltase, intestinalHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMu-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
sensory perceptionMu-type opioid receptorHomo sapiens (human)
negative regulation of cell population proliferationMu-type opioid receptorHomo sapiens (human)
sensory perception of painMu-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
behavioral response to ethanolMu-type opioid receptorHomo sapiens (human)
positive regulation of neurogenesisMu-type opioid receptorHomo sapiens (human)
negative regulation of Wnt protein secretionMu-type opioid receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMu-type opioid receptorHomo sapiens (human)
calcium ion transmembrane transportMu-type opioid receptorHomo sapiens (human)
cellular response to morphineMu-type opioid receptorHomo sapiens (human)
regulation of cellular response to stressMu-type opioid receptorHomo sapiens (human)
regulation of NMDA receptor activityMu-type opioid receptorHomo sapiens (human)
neuropeptide signaling pathwayMu-type opioid receptorHomo sapiens (human)
immune responseDelta-type opioid receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerDelta-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
adult locomotory behaviorDelta-type opioid receptorHomo sapiens (human)
negative regulation of gene expressionDelta-type opioid receptorHomo sapiens (human)
negative regulation of protein-containing complex assemblyDelta-type opioid receptorHomo sapiens (human)
positive regulation of CREB transcription factor activityDelta-type opioid receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationDelta-type opioid receptorHomo sapiens (human)
response to nicotineDelta-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor signaling pathwayDelta-type opioid receptorHomo sapiens (human)
eating behaviorDelta-type opioid receptorHomo sapiens (human)
regulation of mitochondrial membrane potentialDelta-type opioid receptorHomo sapiens (human)
regulation of calcium ion transportDelta-type opioid receptorHomo sapiens (human)
cellular response to growth factor stimulusDelta-type opioid receptorHomo sapiens (human)
cellular response to hypoxiaDelta-type opioid receptorHomo sapiens (human)
cellular response to toxic substanceDelta-type opioid receptorHomo sapiens (human)
neuropeptide signaling pathwayDelta-type opioid receptorHomo sapiens (human)
immune responseKappa-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayKappa-type opioid receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayKappa-type opioid receptorHomo sapiens (human)
chemical synaptic transmissionKappa-type opioid receptorHomo sapiens (human)
sensory perceptionKappa-type opioid receptorHomo sapiens (human)
locomotory behaviorKappa-type opioid receptorHomo sapiens (human)
sensory perception of painKappa-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting opioid receptor signaling pathwayKappa-type opioid receptorHomo sapiens (human)
response to insulinKappa-type opioid receptorHomo sapiens (human)
positive regulation of dopamine secretionKappa-type opioid receptorHomo sapiens (human)
negative regulation of luteinizing hormone secretionKappa-type opioid receptorHomo sapiens (human)
response to nicotineKappa-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor signaling pathwayKappa-type opioid receptorHomo sapiens (human)
maternal behaviorKappa-type opioid receptorHomo sapiens (human)
eating behaviorKappa-type opioid receptorHomo sapiens (human)
response to estrogenKappa-type opioid receptorHomo sapiens (human)
estrous cycleKappa-type opioid receptorHomo sapiens (human)
response to ethanolKappa-type opioid receptorHomo sapiens (human)
regulation of saliva secretionKappa-type opioid receptorHomo sapiens (human)
behavioral response to cocaineKappa-type opioid receptorHomo sapiens (human)
sensory perception of temperature stimulusKappa-type opioid receptorHomo sapiens (human)
defense response to virusKappa-type opioid receptorHomo sapiens (human)
cellular response to lipopolysaccharideKappa-type opioid receptorHomo sapiens (human)
cellular response to glucose stimulusKappa-type opioid receptorHomo sapiens (human)
positive regulation of p38MAPK cascadeKappa-type opioid receptorHomo sapiens (human)
positive regulation of potassium ion transmembrane transportKappa-type opioid receptorHomo sapiens (human)
response to acrylamideKappa-type opioid receptorHomo sapiens (human)
positive regulation of eating behaviorKappa-type opioid receptorHomo sapiens (human)
conditioned place preferenceKappa-type opioid receptorHomo sapiens (human)
neuropeptide signaling pathwayKappa-type opioid receptorHomo sapiens (human)
pentose-phosphate shunt6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
pentose-phosphate shunt, oxidative branch6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
pentose biosynthetic process6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
D-gluconate catabolic process6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
carbohydrate metabolic processProbable maltase-glucoamylase 2Homo sapiens (human)
glycoprotein catabolic processSialidase-2Homo sapiens (human)
ganglioside catabolic processSialidase-2Homo sapiens (human)
oligosaccharide catabolic processSialidase-2Homo sapiens (human)
glycosphingolipid catabolic processSialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
catalytic activityMaltase-glucoamylase, intestinalHomo sapiens (human)
glucan 1,4-alpha-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
alpha-1,4-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
protein bindingMaltase-glucoamylase, intestinalHomo sapiens (human)
amylase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
carbohydrate bindingMaltase-glucoamylase, intestinalHomo sapiens (human)
maltose alpha-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
alpha-1,4-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
carbohydrate bindingLysosomal alpha-glucosidaseHomo sapiens (human)
maltose alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
oligo-1,6-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
sucrose alpha-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
protein bindingSucrase-isomaltase, intestinalHomo sapiens (human)
carbohydrate bindingSucrase-isomaltase, intestinalHomo sapiens (human)
alpha-1,4-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
G-protein alpha-subunit bindingMu-type opioid receptorHomo sapiens (human)
G protein-coupled receptor activityMu-type opioid receptorHomo sapiens (human)
beta-endorphin receptor activityMu-type opioid receptorHomo sapiens (human)
voltage-gated calcium channel activityMu-type opioid receptorHomo sapiens (human)
protein bindingMu-type opioid receptorHomo sapiens (human)
morphine receptor activityMu-type opioid receptorHomo sapiens (human)
G-protein beta-subunit bindingMu-type opioid receptorHomo sapiens (human)
neuropeptide bindingMu-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor activityDelta-type opioid receptorHomo sapiens (human)
protein bindingDelta-type opioid receptorHomo sapiens (human)
receptor serine/threonine kinase bindingDelta-type opioid receptorHomo sapiens (human)
G protein-coupled enkephalin receptor activityDelta-type opioid receptorHomo sapiens (human)
neuropeptide bindingDelta-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor activityKappa-type opioid receptorHomo sapiens (human)
protein bindingKappa-type opioid receptorHomo sapiens (human)
receptor serine/threonine kinase bindingKappa-type opioid receptorHomo sapiens (human)
dynorphin receptor activityKappa-type opioid receptorHomo sapiens (human)
neuropeptide bindingKappa-type opioid receptorHomo sapiens (human)
phosphogluconate dehydrogenase (decarboxylating) activity6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
NADP binding6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
glucan 1,4-alpha-glucosidase activityProbable maltase-glucoamylase 2Homo sapiens (human)
carbohydrate bindingProbable maltase-glucoamylase 2Homo sapiens (human)
alpha-1,4-glucosidase activityProbable maltase-glucoamylase 2Homo sapiens (human)
exo-alpha-sialidase activitySialidase-2Homo sapiens (human)
protein bindingSialidase-2Homo sapiens (human)
exo-alpha-(2->3)-sialidase activitySialidase-2Homo sapiens (human)
exo-alpha-(2->6)-sialidase activitySialidase-2Homo sapiens (human)
exo-alpha-(2->8)-sialidase activitySialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (50)

Processvia Protein(s)Taxonomy
plasma membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
apical plasma membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
extracellular exosomeMaltase-glucoamylase, intestinalHomo sapiens (human)
tertiary granule membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
ficolin-1-rich granule membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
lysosomeLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal membraneLysosomal alpha-glucosidaseHomo sapiens (human)
plasma membraneLysosomal alpha-glucosidaseHomo sapiens (human)
membraneLysosomal alpha-glucosidaseHomo sapiens (human)
azurophil granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal lumenLysosomal alpha-glucosidaseHomo sapiens (human)
intracellular membrane-bounded organelleLysosomal alpha-glucosidaseHomo sapiens (human)
extracellular exosomeLysosomal alpha-glucosidaseHomo sapiens (human)
tertiary granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
ficolin-1-rich granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
autolysosome lumenLysosomal alpha-glucosidaseHomo sapiens (human)
Golgi apparatusSucrase-isomaltase, intestinalHomo sapiens (human)
plasma membraneSucrase-isomaltase, intestinalHomo sapiens (human)
brush borderSucrase-isomaltase, intestinalHomo sapiens (human)
apical plasma membraneSucrase-isomaltase, intestinalHomo sapiens (human)
extracellular exosomeSucrase-isomaltase, intestinalHomo sapiens (human)
endosomeMu-type opioid receptorHomo sapiens (human)
endoplasmic reticulumMu-type opioid receptorHomo sapiens (human)
Golgi apparatusMu-type opioid receptorHomo sapiens (human)
plasma membraneMu-type opioid receptorHomo sapiens (human)
axonMu-type opioid receptorHomo sapiens (human)
dendriteMu-type opioid receptorHomo sapiens (human)
perikaryonMu-type opioid receptorHomo sapiens (human)
synapseMu-type opioid receptorHomo sapiens (human)
plasma membraneMu-type opioid receptorHomo sapiens (human)
neuron projectionMu-type opioid receptorHomo sapiens (human)
plasma membraneDelta-type opioid receptorHomo sapiens (human)
synaptic vesicle membraneDelta-type opioid receptorHomo sapiens (human)
dendrite membraneDelta-type opioid receptorHomo sapiens (human)
presynaptic membraneDelta-type opioid receptorHomo sapiens (human)
axon terminusDelta-type opioid receptorHomo sapiens (human)
spine apparatusDelta-type opioid receptorHomo sapiens (human)
postsynaptic density membraneDelta-type opioid receptorHomo sapiens (human)
neuronal dense core vesicleDelta-type opioid receptorHomo sapiens (human)
plasma membraneDelta-type opioid receptorHomo sapiens (human)
neuron projectionDelta-type opioid receptorHomo sapiens (human)
nucleoplasmKappa-type opioid receptorHomo sapiens (human)
mitochondrionKappa-type opioid receptorHomo sapiens (human)
cytosolKappa-type opioid receptorHomo sapiens (human)
plasma membraneKappa-type opioid receptorHomo sapiens (human)
membraneKappa-type opioid receptorHomo sapiens (human)
sarcoplasmic reticulumKappa-type opioid receptorHomo sapiens (human)
T-tubuleKappa-type opioid receptorHomo sapiens (human)
dendriteKappa-type opioid receptorHomo sapiens (human)
synaptic vesicle membraneKappa-type opioid receptorHomo sapiens (human)
presynaptic membraneKappa-type opioid receptorHomo sapiens (human)
perikaryonKappa-type opioid receptorHomo sapiens (human)
axon terminusKappa-type opioid receptorHomo sapiens (human)
postsynaptic membraneKappa-type opioid receptorHomo sapiens (human)
plasma membraneKappa-type opioid receptorHomo sapiens (human)
neuron projectionKappa-type opioid receptorHomo sapiens (human)
nucleus6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
cytosol6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
extracellular exosome6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
cytosol6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
membraneProbable maltase-glucoamylase 2Homo sapiens (human)
cytosolSialidase-2Homo sapiens (human)
catalytic complexSialidase-2Homo sapiens (human)
lysosomeSialidase-2Homo sapiens (human)
membraneSialidase-2Homo sapiens (human)
cytoplasmSialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (63)

Assay IDTitleYearJournalArticle
AID311282Antagonist activity at human delta opioid receptor expressed in CHO cells by [35S]GTPgammaS assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID333442Effect on COX1 activity in sheep seminal vesicle at 5 uM by TMPD peroxidase assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID319369Inhibition of yeast G6PD2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID257317Inhibitory activity against barley beta amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID358235Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio by Trypan blue method2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID1102155Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID319372Inhibition of G6PD-mediated NADPH production in mouse 3T3-L1 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID466939Selectivity for Trypanosoma cruzi trans-sialidase mutant over human Neu22010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID1102120Phytotoxicity in Bassia scoparia assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1441288Inhibition of hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 40 mins by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID1102158Phytotoxicity in Centaurea maculosa assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID319371Inhibition of IDH2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID333440Inhibition of cyclooxygenase activity of COX1 in sheep seminal vesicle in presence of 1 mM phenol by cyclooxygenase assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID265763Inhibition of FabZ at 100 uM2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID358236Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio by Trypan blue method2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID1102118Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1102122Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1465954Inhibition of SPI-1 T3SS in Salmonella typhimurium expressing SopE2-CPG2-HA fusion protein assessed as reduction in type 3 protein secretion using Glu-CyFur as substrate at 25 uM after 4 hrs by fluorescence assay2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID752787Inhibition of porcine pancreatic lipase using para-nitrophenyl butyrate as substrate at 100 uM by ELISA2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects.
AID311280Antagonist activity at human kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID647808Antifilarial activity against adult Brugia malayi assessed as inhibition of motility at 31.25 ug/ml incubated for 48 hrs followed by washout measured after 1 hr in the absence of drug by microscopic analysis2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
AID319375Ratio of IC50 for yeast G6PD to IC50 for G6PD-mediated NADPH production in mouse 3T3-L1 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1102157Phytotoxicity in Centaurea diffusa assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1102154Phytotoxicity in Arabidopsis thaliana assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1102123Phytotoxicity in Centaurea maculosa assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID333444Binding affinity to COX1 in sheep seminal vesicle2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID311281Antagonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID466937Inhibition of Trypanosoma cruzi trans-sialidase containing catalytic domain (N58F, R200K) and lectin-like domain (S495 K, V496G, E520K, D593G, I597D, H599R) mutation expressed in Escherichia coli JM109 assessed as MuNANA substrate hydrolysis in presence o2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID358237Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio by Trypan blue method2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID333445Inhibition of human COX2 expressed in baculovirus infected Sf-21 insect cells2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID358233Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 10 molar ratio relative to TPA2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID358234Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio by Trypan blue method2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID265762Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID265761Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF542006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID358230Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio relative to TPA2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID437510Inhibition of MET kinase2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID311284Selectivity for antagonist activity at human delta opioid receptor to kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID265765Inhibition of FabG at 100 uM2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID311283Selectivity for antagonist activity at human mu opioid receptor to kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S assay2007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID265764Inhibition of FabI at 100 uM2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID311288Agonist activity at opioid receptor relative to U69,5932007Journal of natural products, Aug, Volume: 70, Issue:8
Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships.
AID1102121Phytotoxicity in Centaurea diffusa assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1102156Phytotoxicity in Bassia scoparia assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID333443Inactivation of holo-COX1 in sheep seminal vesicle assessed as drug oxidization at 2.5 to 4 nmol by RP-HPLC in presence of hydrogen peroxide2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID358231Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 500 molar ratio relative to TPA2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID257316Inhibitory activity against Bacillus licheniformis alpha amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID257315Inhibitory activity against baker's yeast alpha glucosidase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID466938Inhibition of human Neu2 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID333439Inhibition of peroxidase activity of COX1 in heep seminal vesicle by TMPD assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
AID647813Antifilarial activity against microfilariae Brugia malayi assessed as inhibition of motility at 31.25 ug/ml incubated for 48 hrs followed by washout measured after 1 hr in the absence of drug by microscopic analysis2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
AID319370Inhibition of 6PGD2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1102119Phytotoxicity in Arabidopsis thaliana assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1514076Inhibition of alpha-glucosidase (unknown origin) using p-nitrophenyl beta-D-glucopyranoside as substrate measured after 20 mins2019Bioorganic & medicinal chemistry letters, 01-01, Volume: 29, Issue:1
Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors.
AID1102117Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of seed germination at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID44249Inhibition of human Beta-secretase 12003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Green tea catechins as a BACE1 (beta-secretase) inhibitor.
AID647818Antifilarial activity against adult Brugia malayi at 31.25 ug/ml by MTT assay relative to control2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
AID772994Relative antioxidant activity assessed as resorcinol equivalents of hydroperoxyl scavenging activity at acidic pH by BR oscillating reaction method2013European journal of medicinal chemistry, Oct, Volume: 68Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
AID358232Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 100 molar ratio relative to TPA2001Journal of natural products, Oct, Volume: 64, Issue:10
New phenylpropanoid esters of sucrose from Polygonum lapathifolium.
AID1102153Phytotoxicity in Solanum lycopersicum (tomato) assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1102152Phytotoxicity in Triticum aestivum (wheat) assessed as increase in mortality at 50 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1705065Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoi2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (47.37)29.6817
2010's9 (47.37)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 65.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index65.37 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index152.52 (26.88)
Search Engine Supply Index2.86 (0.95)

This Compound (65.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]